Your browser doesn't support javascript.
loading
Delineation of the adult phenotype of Coffin-Siris syndrome in 35 individuals.
Schmetz, Ariane; Lüdecke, Hermann-Josef; Surowy, Harald; Sivalingam, Sugirtahn; Bruel, Ange-Line; Caumes, Roseline; Charles, Perrine; Chatron, Nicolas; Chrzanowska, Krystyna; Codina-Solà, Marta; Colson, Cindy; Cuscó, Ivon; Denommé-Pichon, Anne-Sophie; Edery, Patrick; Faivre, Laurence; Green, Andrew; Heide, Solveig; Hsieh, Tzung-Chien; Hustinx, Alexander; Kleinendorst, Lotte; Knopp, Cordula; Kraft, Florian; Krawitz, Peter M; Lasa-Aranzasti, Amaia; Lesca, Gaetan; López-González, Vanesa; Maraval, Julien; Mignot, Cyril; Neuhann, Teresa; Netzer, Christian; Oehl-Jaschkowitz, Barbara; Petit, Florence; Philippe, Christophe; Posmyk, Renata; Putoux, Audrey; Reis, André; Sánchez-Soler, María José; Suh, Julia; Tkemaladze, Tinatin; Tran Mau Them, Frédéric; Travessa, André; Trujillano, Laura; Valenzuela, Irene; van Haelst, Mieke M; Vasileiou, Georgia; Vincent-Delorme, Catherine; Walther, Mona; Verde, Pablo; Bramswig, Nuria C; Wieczorek, Dagmar.
  • Schmetz A; Institute of Human Genetics, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University, Moorenstraße 5, 40225, Düsseldorf, Germany. ariane.schmetz@hhu.de.
  • Lüdecke HJ; Institute of Human Genetics, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University, Moorenstraße 5, 40225, Düsseldorf, Germany.
  • Surowy H; Institute of Human Genetics, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University, Moorenstraße 5, 40225, Düsseldorf, Germany.
  • Sivalingam S; Institute of Human Genetics, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University, Moorenstraße 5, 40225, Düsseldorf, Germany.
  • Bruel AL; Inserm UMR1231 Team GAD, University of Burgundy and Franche-Comté, 21000, Dijon, France.
  • Caumes R; Functional Unit of Innovative Diagnosis for Rare Diseases, Dijon Bourgogne University Hospital, 21000, Dijon, France.
  • Charles P; CHU Lille, Clinique de Génétique, 59000, Lille, France.
  • Chatron N; Assistance Publique-Hôpitaux de Paris, Département de Génétique, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
  • Chrzanowska K; Service de Génétique, Hospices Civils de Lyon, Bron, France.
  • Codina-Solà M; Institute NeuroMyoGène, Laboratoire Physiopathologie et Génétique du Neurone et du Muscle, CNRS UMR 5261-INSERM U1315, Université de Lyon-Université Claude Bernard Lyon 1, Lyon, France.
  • Colson C; Department of Medical Genetics, The Children's Memorial Health Institute, Warsaw, Poland.
  • Cuscó I; Area of Clinical and Molecular Genetics, Vall d'Hebron University Hospital, 08035, Barcelona, Spain.
  • Denommé-Pichon AS; CHU Lille, Clinique de Génétique, 59000, Lille, France.
  • Edery P; Area of Clinical and Molecular Genetics, Vall d'Hebron University Hospital, 08035, Barcelona, Spain.
  • Faivre L; Inserm UMR1231 Team GAD, University of Burgundy and Franche-Comté, 21000, Dijon, France.
  • Green A; Functional Unit of Innovative Diagnosis for Rare Diseases, Dijon Bourgogne University Hospital, 21000, Dijon, France.
  • Heide S; Service de Génétique, Hospices Civils de Lyon, Bron, France.
  • Hsieh TC; Centre de Recherche en Neurosciences de Lyon, Equipe GENDEV, INSERM U1028, UMR CNRS 5292, Université Claude Bernard Lyon 1, Lyon, France.
  • Hustinx A; Inserm UMR1231 Team GAD, University of Burgundy and Franche-Comté, 21000, Dijon, France.
  • Kleinendorst L; Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs, Fédération Hospitalo-Universitaire TRANSLAD et Institut GIMI, Dijon Bourgogne University Hospital, 21000, Dijon, France.
  • Knopp C; Department of Clinical Genetics, Children's Health Ireland at Crumlin, and University College Dublin School of Medicine and Medical Science, Dublin, Ireland.
  • Kraft F; Assistance Publique-Hôpitaux de Paris, Département de Génétique, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
  • Krawitz PM; Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.
  • Lasa-Aranzasti A; Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.
  • Lesca G; Department of Clinical Genetics, Amsterdam UMC, Amsterdam, The Netherlands.
  • López-González V; Institute for Human Genetics and Genomic Medicine, Medical Faculty, RWTH Aachen University Hospital, 52074, Aachen, Germany.
  • Maraval J; Institute for Human Genetics and Genomic Medicine, Medical Faculty, RWTH Aachen University Hospital, 52074, Aachen, Germany.
  • Mignot C; Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.
  • Neuhann T; Area of Clinical and Molecular Genetics, Vall d'Hebron University Hospital, 08035, Barcelona, Spain.
  • Netzer C; Service de Génétique, Hospices Civils de Lyon, Bron, France.
  • Oehl-Jaschkowitz B; Institute NeuroMyoGène, Laboratoire Physiopathologie et Génétique du Neurone et du Muscle, CNRS UMR 5261-INSERM U1315, Université de Lyon-Université Claude Bernard Lyon 1, Lyon, France.
  • Petit F; Sección Genética Médica, Servicio de Pediatría, Hospital Clínico Universitario Virgen de la Arrixaca (HCUVA), IMIB-Arrixaca, El Palmar, Murcia, Spain.
  • Philippe C; Inserm UMR1231 Team GAD, University of Burgundy and Franche-Comté, 21000, Dijon, France.
  • Posmyk R; Centre de Référence Déficiences Intellectuelles de Causes Rares, Dijon Bourgogne University Hospital, 21000, Dijon, France.
  • Putoux A; Assistance Publique-Hôpitaux de Paris, Département de Génétique, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
  • Reis A; Medizinisch Genetisches Zentrum, Munich, Germany.
  • Sánchez-Soler MJ; Institute of Human Genetics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Suh J; Center for Rare Diseases, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Tkemaladze T; BIOSCIENTIA MVZ Labor Saar, Praxis Für Humangenetik, Homburg Saar, Germany.
  • Tran Mau Them F; CHU Lille, Clinique de Génétique, 59000, Lille, France.
  • Travessa A; Inserm UMR1231 Team GAD, University of Burgundy and Franche-Comté, 21000, Dijon, France.
  • Trujillano L; Functional Unit of Innovative Diagnosis for Rare Diseases, Dijon Bourgogne University Hospital, 21000, Dijon, France.
  • Valenzuela I; Laboratory of Human Genetics, CHR Metz Thionville, Hôpital Mercy, Metz, France.
  • van Haelst MM; Department of Clinical Genetics, Medical University in Bialystok, Bialystok, Poland.
  • Vasileiou G; Service de Génétique, Hospices Civils de Lyon, Bron, France.
  • Vincent-Delorme C; Centre de Recherche en Neurosciences de Lyon, Equipe GENDEV, INSERM U1028, UMR CNRS 5292, Université Claude Bernard Lyon 1, Lyon, France.
  • Walther M; Institute of Human Genetics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054, Erlangen, Germany.
  • Verde P; Centre for Rare Diseases Erlangen (ZSEER), 91054, Erlangen, Germany.
  • Bramswig NC; Sección Genética Médica, Servicio de Pediatría, Hospital Clínico Universitario Virgen de la Arrixaca (HCUVA), IMIB-Arrixaca, El Palmar, Murcia, Spain.
  • Wieczorek D; Institute for Human Genetics and Genomic Medicine, Medical Faculty, RWTH Aachen University Hospital, 52074, Aachen, Germany.
Hum Genet ; 143(1): 71-84, 2024 Jan.
Article en En | MEDLINE | ID: mdl-38117302
ABSTRACT
Coffin-Siris syndrome (CSS) is a rare multisystemic autosomal dominant disorder. Since 2012, alterations in genes of the SWI/SNF complex were identified as the molecular basis of CSS, studying largely pediatric cohorts. Therefore, there is a lack of information on the phenotype in adulthood, particularly on the clinical outcome in adulthood and associated risks. In an international collaborative effort, data from 35 individuals ≥ 18 years with a molecularly ascertained CSS diagnosis (variants in ARID1B, ARID2, SMARCA4, SMARCB1, SMARCC2, SMARCE1, SOX11, BICRA) using a comprehensive questionnaire was collected. Our results indicate that overweight and obesity are frequent in adults with CSS. Visual impairment, scoliosis, and behavioral anomalies are more prevalent than in published pediatric or mixed cohorts. Cognitive outcomes range from profound intellectual disability (ID) to low normal IQ, with most individuals having moderate ID. The present study describes the first exclusively adult cohort of CSS individuals. We were able to delineate some features of CSS that develop over time and have therefore been underrepresented in previously reported largely pediatric cohorts, and provide recommendations for follow-up.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anomalías Múltiples / Deformidades Congénitas de la Mano / Cara / Discapacidad Intelectual / Micrognatismo Límite: Adult / Child / Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anomalías Múltiples / Deformidades Congénitas de la Mano / Cara / Discapacidad Intelectual / Micrognatismo Límite: Adult / Child / Humans Idioma: En Año: 2024 Tipo del documento: Article